Environmental Health Network |
EHN P.O. Box 1155 Larkspur, California, 94977 Support and Information Line (SAIL) 415.541.5075 |
Role of Neural Plasticity in Chemical Intolerance The New York Academy of Sciences is sponsoring a conference entitled: Role of Neural Plasticity in Chemical Intolerance in June, 2000. The principal investigator and chair is Barbara Sorg, Ph.D., Washington State University. The co-chair is Iris Bell, M.D., Ph.D., Tucson Veterans Affairs Medical Center. Chemical intolerance (CI), also referred to as multiple chemical sensitivity, is a condition whereby individuals become increasingly sensitive to chemicals in the home and workplace. It is an emerging problem in environmental health. A wide variety of symptoms and severe illness from lowlevel chemical exposures have been reported in as high as 46% of the American population. Individuals with sensitivities to chemicals make an average of 23 health care provider visits per year. Thus, the economic impact of the CI condition and lack of treatment is potentially enormous. The main objective of the meeting is to gather neuroscientists from a variety of subdisciplines to discuss the potential mechanisms for the amplification of symptoms in individuals with CI. The meeting will provide a forum for the exchange of ideas in these subdisciplines in an effort to develop a series of testable hypotheses based upon the postulate that neural plasticity plays a role in the development of CI. While the primary focus of the meeting is on preclinical data, the program will also include scientists who will provide uptodate information on the clinical aspects of CI. It is expected that these presentations by clinical and basic scientists will familiarize the audience with not only the primary clinical findings of CI but also basic biological findings related to neural plasticity as a potential critical link for mechanisms leading to CI in humans. The basic science findings will focus primarily on the cellular changes that mediate plasticity as well as alterations in brain pathways that regulate behavior. The findings will be integrated into a rationale for future basic research and clinical applications. Ultimately, the goal is to provide a greater understanding of the mechanism(s) of CI so that treatment strategies may be developed. The proceedings will be published as a volume in the Annals of the New York Academy of Sciences and will be distributed internationally. This conference is unique in that it will focus on neurobiological changes which may occur in individuals with chemical intolerance, or CI. Neurological symptoms are the number one complaint among those with CI, and we feel it is time to move our research efforts toward an understanding of the basic mechanisms underlying the neurological changes that may occur in CI. Many of the speakers planned for the conference are among the top research scientists in their various subdisciplines, and nearly all have agreed to participate in the meeting. CONFERENCE PROGRAM: Role of Neural Plasticity in Chemical Intolerance Friday, June 16, 2000 7:00-9:00 pm ..... Wine and cheese reception Saturday, June 17, 2000 (POSTER SESSION: Posters set up by 12:00 Saturday, viewing/discussion Sunday, 5:30-7:30 pm) 8:00-8:30 am ..... Opening Remarks (Brief introduction by Drs. Bell and Sorg)
Session I: Chemical Intolerance in Humans
8:30-9:00 am ..... Claudia S. Miller, M.D., M.S.
9:00-9:30 am ..... Nancy Fiedler, Ph.D.
9:30-10:00 am ..... Gerd Kobal, M.D.
10:50-11:20 am ..... Donald W. Black, M.D.
11:20-12:10 am ..... Bernard D. Goldstein, M.D.
ALTERNATE Gilbert S. Omenn, MD., Ph.D. 12:10-12:30 ..... Discussion with Panelists (Session I speakers)
Chairperson: Robert C. MacPhail, Ph.D.
2:00-2:30 pm ..... Barbara A. Sorg, Ph.D.
2:30-3:00 pm ..... Mary E. Gilbert, PhD
3:00-3:30 pm ..... David H. Overstreet, Ph.D.
3:30-3:50 pm ..... Coffee break 4:20-4:45 pm ..... Discussion with Panelists (Sessions II speakers) 6:30 pm ..... Speaker's Dinner
Sunday, June 18, 2000
Session III: Neurogenic Inflammation
8:00-8:30 am ..... Rebecca Bascom, M.D., M.P.H.
8:30-9:00 am ..... Jon D. Levine, M.D., Ph.D.
Session IV: Neural Plasticity in Pathological Pain
9:00-9:30 am ..... Holger Ursin, Ph.D.
9:30-10:00 am ..... M. Catherine Bushnell, Ph.D. 10:00-10:20 am ..... Coffee break
10:20-10:50 am ..... Jianren Mao, M.D., Ph.D.
10:50-11:20 am ..... William D. Willis, Jr, MD. PhD
11:20-11:50 am ..... Ronald Melzack, Ph.D.
11:50-12:15 pm ..... Discussion with Panelists (Session III and IV speakers)
12:15-2:00 pm ..... Lunch
Session V: Cytokines, Chronic Fatigue States and Sickness Behavior
2:00-2:30 pm ..... Roberto Patarca, M.D., Ph.D.
2:30-3:00 pm ..... Harvey Moldofsky, M.D.
3:00-3:30 pm ..... James M. Krueger, PhD 3:30-3:50 pm ..... Coffee break
3:50-4:20 pm ..... Robert Dantzer, Ph.D.
4:20-4:40 pm ..... Daniel J. Clauw, M.D.
4:40-5:00 pm ..... Discussion with Panelists (Session V speakers) Monday, June 19, 2000
Session VI: Physiological stress and the neuroendocrine axis
8:00-8:30 am George P. Chrousos, M.D., S.C.D.
8:30-9:00 am ..... Catherine G. Rivier, PhD
9:00-9:30 am ..... Bruce S. McEwen, Ph.D. 9:30-9:50 am ..... Discussion with Panelists (Session VI speakers)
10:40-11:10 am ..... Joseph E. LeDoux, Ph.D
ALTERNATE Michael S. Fanselow, PhD
11:10-11:40 pm ..... Timothy A. Otto, Ph.D 11:40-12:00 pm ..... Panelist Discussion (Session VII speakers) 12:00-12:30 pm ..... General Discussion open to public
|
Return to Press Release Index
As with all organizations, EHN depends upon your contributions of time and energy, as well as your membership support.
http://www.ehnca.org/www/Press Releases/fragfda3.htm --2/7/00
The Environmental Health Network (EHN) [of California] is a 501 (c) (3) non profit agency and offers support and information for the chemically injured. EHN brings you topics on this page that need your immediate attention The URL for this page is http://www.ehnca.org/www/FDApetition/fragmisbt.htm